Virobay Company
Virobay develops small molecule, antiviral drug treatments for autoimmune diseases, neuropathic pain, liver diseases, and cancer.
Employee Number:
1-10
Funding Status:
IPO
Headquarters:
Menlo Park, California, United States
Technology:
Biologics
Estimated Revenue:
$1M to $10M
Founded Date:
2006
Industry:
PharmTech